• CoreCivic recently completed the sale of four facilities, including two ICE detention centers sold to the U.S. government for an aggregate US$734.0 million, raised full-year 2026 earnings guidance to US$1.50–US$1.52 billion in net income and US$15.00–US$15.20 in diluted EPS, and used part of the proceeds to repay US$608.5 million of debt while expanding its share repurchase authorization to US$1.20 billion.
• Although these asset sales generate a very large accounting gain in 2026, CoreCivic still expects to keep operating the sold ICE facilities under existing management contracts, which could help preserve operational cash flows even as ownership shifts to the federal government.
• We’ll now examine how the one-time earnings boost from facility sales and debt reduction could reshape CoreCivic’s longer-term investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.

CoreCivic Investment Narrative Recap

To own CoreCivic, you have to believe federal detention demand and funding will remain supportive enough for its facilities and management contracts to stay well utilized. The key short term catalyst is how ICE and the U.S. Marshals Service renew and structure contracts, while the biggest risk is any policy shift away from privately run detention. The recent facility sales and debt paydown strengthen the balance sheet but do not remove that policy and contract renewal risk.

The most relevant update here is CoreCivic’s sharply higher 2026 earnings guidance to US$1.50–US$1.52 billion in net income and US$15.00–US$15.20 diluted EPS, largely driven by one time gains on facility sales and lower interest expense. This accounting step up does not automatically improve the quality or durability of future earnings, but it does give CoreCivic more financial flexibility as it heads into upcoming contract discussions with its largest federal partners.

Yet beneath the headline earnings boost, investors should be aware of how dependent this story still is on future federal detention policy and...

CoreCivic's narrative projects $3.3 billion revenue and $307.9 million earnings by 2029. This requires 10.1% yearly revenue growth and about a $180 million earnings increase from $127.9 million today.

Uncover how CoreCivic's forecasts yield a $39.60 fair value, a 23% upside to its current price.

Exploring Other Perspectives

Some analysts were already assuming revenue could reach about US$3.1 billion and earnings US$246 million by 2029, so compared with baseline views they paint a far more optimistic picture that could shift again after these asset sales and the growing risk ICE may increasingly own facilities outright.

Explore 3 other fair value estimates on CoreCivic - why the stock might be worth as much as 23% more than the current price!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your CoreCivic research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free CoreCivic research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate CoreCivic's overall financial health at a glance.

Searching For A Fresh Perspective?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Uncover the next big thing with 20 elite penny stocks that balance risk and reward.
• The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.